BioInvent International Valuation
| BINV Stock | SEK 44.55 1.20 2.62% |
At this time, the firm appears to be overvalued. BioInvent International shows a prevailing Real Value of kr37.62 per share. The current price of the firm is kr44.55. Our model approximates the value of BioInvent International from analyzing the firm fundamentals such as Return On Equity of -0.0274, current valuation of 1.16 B, and Profit Margin of (0.14) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BioInvent International's price fluctuation is not too volatile at this time. Calculation of the real value of BioInvent International is based on 3 months time horizon. Increasing BioInvent International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
BioInvent International's intrinsic value may or may not be the same as its current market price of 44.55, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 44.55 | Real 37.62 | Hype 44.55 | Naive 41.36 |
The intrinsic value of BioInvent International's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioInvent International's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioInvent International AB helps investors to forecast how BioInvent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioInvent International more accurately as focusing exclusively on BioInvent International's fundamentals will not take into account other important factors: BioInvent International Total Value Analysis
BioInvent International AB is currently anticipated to have takeover price of 1.16 B with market capitalization of 1.99 B, debt of 21.53 M, and cash on hands of 28.46 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BioInvent International fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.16 B | 1.99 B | 21.53 M | 28.46 M |
BioInvent International Investor Information
About 57.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.4. Some equities with similar Price to Book (P/B) outperform the market in the long run. BioInvent International recorded a loss per share of 4.56. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 14th of December 2020. Based on the analysis of BioInvent International's profitability, liquidity, and operating efficiency, BioInvent International AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.BioInvent International Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BioInvent International has an asset utilization ratio of 1.34 percent. This implies that the Company is making kr0.0134 for each dollar of assets. An increasing asset utilization means that BioInvent International AB is more efficient with each dollar of assets it utilizes for everyday operations.BioInvent International Ownership Allocation
BioInvent International holds a total of 65.8 Million outstanding shares. Over half of BioInvent International's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in BioInvent International. Please watch out for any change in the institutional holdings of BioInvent International as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BioInvent International Profitability Analysis
The company reported the revenue of 19.38 M. Net Loss for the year was (278.44 M) with profit before overhead, payroll, taxes, and interest of 19.38 M.About BioInvent International Valuation
The stock valuation mechanism determines BioInvent International's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of BioInvent International based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioInvent International. We calculate exposure to BioInvent International's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioInvent International's related companies.BioInvent International AB focuses on the research and development of immunomodulating antibodies for the treatment of cancer in Sweden, Europe, and internationally. The Company was founded in 1997 and is based in Lund, Sweden. BioInvent International operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 68 people.
8 Steps to conduct BioInvent International's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BioInvent International's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BioInvent International's valuation analysis, follow these 8 steps:- Gather financial information: Obtain BioInvent International's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BioInvent International's revenue streams: Identify BioInvent International's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BioInvent International's industry and market trends, including the size of the market, growth rate, and competition.
- Establish BioInvent International's growth potential: Evaluate BioInvent International's management, business model, and growth potential.
- Determine BioInvent International's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BioInvent International's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for BioInvent Stock Analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.